HepG2 Cell Resistance against Camptothecin from a Lysosomal Drug Delivery.

about

A Lysosome-Targeting Fluorescence Off-On Probe for Imaging of Nitroreductase and Hypoxia in Live Cells.

P2860

Q51549085-A5292BB0-A450-4320-987C-064F22D1CFFA

P2860

HepG2 Cell Resistance against Camptothecin from a Lysosomal Drug Delivery.

Item

http://www.wikidata.org/entity/Q53817599

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

HepG2 Cell Resistance against Camptothecin from a Lysosomal Drug Delivery.

@en

HepG2 Cell Resistance against Camptothecin from a Lysosomal Drug Delivery.

@nl

type

Item

label

HepG2 Cell Resistance against Camptothecin from a Lysosomal Drug Delivery.

@en

HepG2 Cell Resistance against Camptothecin from a Lysosomal Drug Delivery.

@nl

prefLabel

HepG2 Cell Resistance against Camptothecin from a Lysosomal Drug Delivery.

@en

HepG2 Cell Resistance against Camptothecin from a Lysosomal Drug Delivery.

@nl

P1476

HepG2 Cell Resistance against Camptothecin from a Lysosomal Drug Delivery

@en

P2093

Chulhun Kang

http://www.w3.org/2001/XMLSchema#string

Hoyeon Lee

http://www.w3.org/2001/XMLSchema#string

Hyo Sung Jung

http://www.w3.org/2001/XMLSchema#string

Hyun Mi Jeon

http://www.w3.org/2001/XMLSchema#string

Jung-Won Shin

http://www.w3.org/2001/XMLSchema#string

Soojin Uhm

http://www.w3.org/2001/XMLSchema#string

Sun Dongbang

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and functional expression of a cDNA encoding a mammalian sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin, and lipoate

Requirement of vascular integrin alpha v beta 3 for angiogenesis

Biotin uptake by human intestinal and liver epithelial cells: role of the SMVT system.

Peptides for cell-selective drug delivery.

Mechanism-based tumor-targeting drug delivery system. Validation of efficient vitamin receptor-mediated endocytosis and drug release.

Prodrugs for improving tumor targetability and efficiency.

The camptothecins.

Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.

Prodrugs: design and clinical applications.

Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug.

P304

2695-2700

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ASIA.201500913

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jong Seung Kim

Yun-Cheol Na

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26373261

http://www.w3.org/2001/XMLSchema#string

P921

drug delivery

HepG2 Cell Resistance against Camptothecin from a Lysosomal Drug Delivery.

about

P2860

P2860

HepG2 Cell Resistance against Camptothecin from a Lysosomal Drug Delivery.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921